- MedPointe Inc.
- AstraZeneca PLC
- King Pharmaceuticals Inc.
- Purdue Pharma LP
- Dompe Farmaceutici SPA
- Laboratorios del Dr. Esteve SA
- GlaxoSmithKline PLC
- Pfizer Inc.
- Merck & Co. Inc.
- Johnson & Johnson
- Church & Dwight Co. Inc.
- Jones Pharma Inc.
- Elan Corp. PLC
- Dura Pharmaceuticals Inc.
- Wampole Laboratories
- Alere Inc.
- Agouron Pharmaceuticals Inc.
- Sunovion Pharmaceuticals Inc.
- Aventis SA
- Viatris GMBH
- Bausch & Lomb Inc.
- Pharmion Corp.
- Corus Pharma Inc.
- MedPointe acquires Wallace Lab and Wampole Lab
- MedPointe sells AstraZeneca's Zomig in the US; rights returned early
- Pfizer launches hostile bid for Warner-Lambert
- Pfizer acquires Pharmacia in $59bn all stock deal
- King buys Jones in $3.2bn stock transaction
- Elan acquires Dura Pharmaceuticals for $1.69bn
- Inverness Medical Innovations buys MedPointe's Wampole Lab
- Warner-Lambert buys Agouron for $2.1bn in stock
- Sepracor to co-promote MedPointe's Astelin in US
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.